VISCHER advised Ysios Capital and Kurma Partners. Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised...
You must be a Standard 1 Year member to access this content.
Goodwin advised Sofinnova Partners, Intermediate Capital Group, Tekla et CTI Life Sciences. Jones Day advised Amolyt Pharma. McDermott Will & Emery advised Andera Partners, Novo Holdings...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Kurma Partners, Bpifrance Investissement, BNP Paribas Développement and Majycc e-Santé Invest on the deal. Kurma Partners, Bpifrance Investissement, BNP Paribas Développement and Majycc...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Sectoral Asset Management and Andera Partners on the deal. McDermott Will & Emery advised a syndicate of Amolyt Pharma’s historical investors, including LSP,...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Bird & Bird, McDermott Will & Emery, Weil, Gotshal & Manges, advised on the matter. Bird & Bird advised Coave Therapeutics (Horama SAS) with...
You must be a Standard 1 Year member to access this content.
Dechert advised the investor on the deal. Kurma Partners, BNP Paribas Développement and Bpifrance through its fund Patient Autonomy, completed their investment of a total amount of...
You must be a Standard 1 Year member to access this content.
